A Complete Blood Count (CBC), often referred to as a Complete Hemogram Test, is a foundational diagnostic blood panel that evaluates overall health. It measures essential blood components, including red blood cells (RBCs), white blood cells (WBCs), hemoglobin, hematocrit, and platelets, alongside differential counts and cell indices. This comprehensive profile helps physicians detect a wide range of conditions, such as anemia, active infections, inflammation, clotting disorders, and nutritional deficiencies. By providing a detailed snapshot of cellular health, the CBC Complete Hemogram serves as a routine screening tool and a vital step in monitoring existing medical conditions.

A Complete Blood Count (CBC), often referred to as a Complete Hemogram Test, is a foundational diagnostic blood panel that evaluates overall health. It measures essential blood components, including red blood cells (RBCs), white blood cells (WBCs), hemoglobin, hematocrit, and platelets, alongside differential counts and cell indices. This comprehensive profile helps physicians detect a wide range of conditions, such as anemia, active infections, inflammation, clotting disorders, and nutritional deficiencies. By providing a detailed snapshot of cellular health, the CBC Complete Hemogram serves as a routine screening tool and a vital step in monitoring existing medical conditions.

A Complete Blood Count (CBC) and Peripheral Blood Smear test provide a comprehensive evaluation of your blood's health and cellular structure. The CBC quantifies key components, including red blood cells, white blood cells, hemoglobin, and platelets, to screen for conditions like anemia, infections, and clotting disorders. Complementing this, the peripheral blood smear involves examining a thin layer of blood under a microscope to evaluate the size, shape, and appearance of these cells. Together, these complementary diagnostic tests offer critical insights, helping clinicians identify abnormal cell morphology, detect underlying blood disorders, and effectively guide targeted medical care.

A Carrier Screening Panel for an individual, or solo test, is a vital genetic assessment for anyone planning a family without partner testing or prior family history. It analyzes a person's DNA to identify if they carry recessive gene mutations for severe genetic conditions, including cystic fibrosis, spinal muscular atrophy, or sickle cell anemia. Because carriers typically experience no health symptoms themselves, this test provides essential clarity regarding hidden genetic risks. Identifying single-carrier status enables individuals to proactively discuss future family planning with their partners, seek guidance from genetic counselors, and make fully informed reproductive decisions before pregnancy.

A Carrier Screening Panel for couples is a specialized genetic test designed for prospective parents planning a family. It determines if both partners carry gene mutations for the same inherited recessive disorders, such as cystic fibrosis, spinal muscular atrophy, or fragile X syndrome. Even if both individuals are healthy, carrying the same mutation means there is a 25% risk per pregnancy of passing the condition to their child. By identifying these potential genetic risks beforehand, couples gain vital reproductive insights, enabling them to explore proactive family-planning options, consult expert genetic counselors, and make informed, empowered medical decisions with total confidence.

The Cardiac Profile - OPD Package is a comprehensive outpatient health check designed for the early detection, evaluation, and prevention of cardiovascular diseases.
Tailored for individuals with risk factors such as high blood pressure, diabetes, stress, or a family history of heart conditions, this screening bundle typically includes vital diagnostic evaluations like an Electrocardiogram (ECG), Lipid Profile, Fasting Blood Sugar, and a cardiologist consultation.
By assessing key markers of heart health efficiently in a single visit, this package empowers patients to proactively manage their wellness, prevent critical cardiac events, and ensure long-term vitality.

The Cardiac Profile M test is a comprehensive blood package designed to evaluate overall heart health and assess cardiovascular disease risks. Typically consisting of multiple key parameters, this panel combines a complete lipid profile—measuring cholesterol components like HDL, LDL, and triglycerides—with critical cardiac risk markers. By analyzing these specific biochemical indicators, the test helps clinicians identify hidden vulnerabilities, monitor cholesterol management, and detect early signs of potential heart conditions. It serves as a valuable diagnostic tool for preventive health screenings, enabling timely interventions and personalized lifestyle or therapeutic strategies to protect long-term cardiac wellness.

The Cardiac Profile C test is an advanced, comprehensive diagnostic evaluation designed to provide an in-depth analysis of cardiovascular health and intricate heart disease risks. Building upon standard and intermediate screenings, this specialized panel frequently includes high-sensitivity cardiac markers, advanced lipid fractionations, genetic or inflammatory indicators, and specialized coagulation factors. By detecting subtle vascular inflammation, micro-vascular stress, and precise lipoprotein particle sizes, the Cardiac Profile C test offers clinicians granular insight into a patient's long-term wellness. This high-resolution diagnostic tool enables fully personalized preventive strategies, early intervention, and optimized therapeutic management for long-term cardiac protection.

The Cardiac Profile B test is an advanced diagnostic blood panel utilized to comprehensively assess cardiovascular disease risk and evaluate overall heart health. Beyond standard cholesterol measurements, this extensive panel often evaluates specialized biomarkers such as high-sensitivity C-reactive protein (hs-CRP) for inflammation, homocysteine levels, and specific cardiac risk indicators. By identifying hidden arterial inflammation, metabolic imbalances, and early signs of plaque buildup, the Cardiac Profile B test provides physicians with critical data. This empowers patients and healthcare providers to implement targeted preventative interventions, personalize treatment strategies, and effectively lower the long-term risk of heart attacks and strokes.

The Cardiac Profile A test is a comprehensive blood panel designed to evaluate heart health and assess the risk of cardiovascular disease. This screening typically measures key biomarkers such as a lipid profile (including total cholesterol, HDL, LDL, and triglycerides) and fasting blood glucose to detect early warning signs of heart conditions, atherosclerosis, and diabetes-related risks. By providing clear insights into your metabolic and lipid status, this essential diagnostic test empowers you and your healthcare provider to proactively manage heart health, implement lifestyle changes, and prevent future cardiac complications effectively.

The Carcinoembryonic Antigen (CEA) test is a blood test that measures the levels of CEA, a type of protein typically found in the tissue of developing fetuses. In healthy adults, blood levels of CEA are very low. However, certain types of cancers can cause these levels to rise significantly, most notably colorectal cancer, as well as cancers of the pancreas, breast, lungs, and stomach.
Doctors primarily use the CEA test to monitor how well cancer treatments are working, check for disease recurrence after therapy, or help stage certain malignancies. It serves as an essential biomarker for ongoing cancer management.

The Cancer Detection Panel for Men is a comprehensive diagnostic screening designed to identify potential cancer biomarkers and early-stage malignancies specific to male health.
This multi-test panel typically evaluates key tumor markers such as PSA (Prostate-Specific Antigen) for prostate health, along with blood tests for gastrointestinal, liver, and lung indicators like CEA and AFP. By assessing these biological red flags, the panel helps physicians catch abnormalities before symptoms arise. It is an invaluable preventative tool for proactive health management, enabling early intervention, more effective treatment options, and significantly improved long-term survival outcomes for men.